Cleared Traditional

K073237 - REHASTIM & REHAMOVE

K073237 is an FDA 510(k) clearance for REHASTIM & REHAMOVE, manufactured by Hasomed GmbH. The device is a Class 2 Neurology device with product code GZI cleared through the Traditional 510(k) pathway after a 41-day FDA review.

K073237 · Hasomed GmbH · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2007
Decision
41d
Days
Class 2
Risk

K073237 is an FDA 510(k) clearance for the REHASTIM & REHAMOVE. Classified as Stimulator, Neuromuscular, External Functional (product code GZI), Class II - Special Controls.

Submitted by Hasomed GmbH (Magdeburg, DE). The FDA issued a Cleared decision on December 27, 2007 after a review of 41 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5810 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Hasomed GmbH devices

FDA 510(k) Submission Details - K073237

510(k) Number K073237 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 16, 2007
Decision Date December 27, 2007
Days to Decision 41 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
107d faster than avg
Panel avg: 148d · This submission: 41d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

GZI Device Classification - Class 2, Special Controls

Product Code GZI Stimulator, Neuromuscular, External Functional
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5810
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZI Stimulator, Neuromuscular, External Functional

All 20
Devices cleared under the same product code (GZI) and FDA review panel - the closest regulatory comparables to K073237.
L300 Go System
K190285 · Bioness, Inc. · Mar 2019
L300 Go System
K173682 · Bioness, Inc. · Mar 2018
ODFS Pace XL
K171396 · Odstock Medical, Ltd. · Jan 2018
FORTE ES
K940759 · Chattanooga Group, Inc. · Mar 1995
ROCHE COBAS ARGOS 5 DIFF
K912615 · Roche Diagnostic Systems, Inc. · Sep 1991
SELECT NEUROMUSCULAR STIMULATORS
K903434 · Medtronic Vascular · Aug 1991